Country: অস্ট্রেলিয়া
ভাষা: ইংরেজি
সূত্র: Department of Health (Therapeutic Goods Administration)
gliclazide, Quantity: 80 mg
Servier Laboratories (Aust) Pty Ltd
Tablet, film coated
Excipient Ingredients: pregelatinised maize starch; maize starch; magnesium stearate; lactose monohydrate; purified talc
Oral
100 tablets, 20 tablets
(S4) Prescription Only Medicine
INDICATIONS AS AT 3 November 1999: Diabetes mellitus of the maturity onset type, which cannot be controlled by diet alone.
Visual Identification: 8 mm, round white tablet, cross-scored on one side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
1999-11-19
GLYADE ® _Immediate release tablets containing gliclazide (pronounced gli-cla-zide)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about GLYADE. It does not contain all the available information Reading this leaflet does not take the place of talking to your doctor, pharmacist, or diabetes educator. All medicines have risks and benefits. Your doctor has weighed the risks of you taking GLYADE against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR, PHARMACIST, OR DIABETES EDUCATOR. KEEP THIS LEAFLET WITH THE MEDICINE. YOU MAY NEED TO READ IT AGAIN. WHAT GLYADE IS The name of your medicine is GLYADE. GLYADE contains the active ingredient 'gliclazide'. Gliclazide belongs to a group of medicines called sulphonylureas. WHAT GLYADE IS USED FOR GLYADE is used to control blood glucose (sugar) in patients with Type II diabetes mellitus. This type of diabetes is also known as non- insulin-dependent diabetes (NIDDM), or maturity-onset diabetes). _WHY GLYADE IS USED FOR_ _TYPE II DIABETES MELLITUS_ GLYADE is used when diet and exercise are not enough to control your blood glucose. GLYADE can be used alone or together with insulin or other medicines for treating diabetes. _HOW IT WORKS_ Glucose is used by the body as fuel, and all people have glucose circulating in their blood. In diabetes, levels of blood glucose are higher than is needed, which is also known as hyperglycaemia. If your blood glucose is not properly controlled, you may experience hypoglycaemia (low blood glucose) or hyperglycaemia (high blood glucose). High blood glucose can lead to serious problems with our heart, circulation and/or kidneys. It is very important to control high blood glucose whether or not you feel unwell. This really helps to avoid serious long-term health problems, which can involve the heart, eyes, circulation, and/or kidneys. A SECTION AT THE END OF THIS LEAFLET CONTAINS ADVICE ABOUT RECOGNISING AND TREATING HYPERGLYCAE সম্পূর্ণ নথি পড়ুন
AUSTRALIAN PRODUCT INFORMATION GLYADE ® TABLET, FILM COATED Version: 11a 1/12 AUSTRALIAN PRODUCT INFORMATION GLYADE ® TABLET, FILM COATED 1 NAME OF THE MEDICINE Gliclazide 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each GLYADE tablet contains 80 mg of gliclazide. Gliclazide is an oral hypoglycaemic sulphonylurea which differs from other related compounds by an N-containing heterocyclic ring with an endocyclic bond. Excipient with known effect: each tablet contains 45 mg of lactose monohydrate. For the full list of excipients, see _section 6.1 - List of excipients_. 3 PHARMACEUTICAL FORM Film-coated tablet: white, round, cross-scored on one side. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS Diabetes mellitus of the maturity onset type, which cannot be controlled by diet alone. 4.2 D OSE AND METHOD OF ADMINISTRATION For adult use only. GLYADE should be taken with food because there is increased risk of hypoglycemia if a meal is taken late, if an inadequate amount of food is consumed or if the food is low in carbohydrate. It is recommended that the medication be taken at breakfast time. If a dose is forgotten, the dose taken on the next day should not be increased. The daily dose may vary from 40 to 320 mg taken orally. The initial recommended dose is 40 mg (half tablet) daily, even in elderly patients (≥ 65 years) and may be increased if necessary up to 320 mg (four tablets) daily. Doses up to 160 mg daily may be taken in a single dose but preferably at the same time each morning. Doses in excess of 160 mg should be taken in divided doses in the morning and evening. In general, the dosage will depend on the severity of the glycaemia with ongoing adjustments made in order to obtain the optimal response at the lowest dosage. Treatment with gliclazide does not obviate the necessity of maintaining standard dietary regulations. 4.3 C ONTRAINDICATIONS This medication is contra-indicated in the following cases: AUSTRALIAN PRODUCT INFORMATION GLYADE ® TABLET, FILM COATED Version: 11a 2/12 − hypersensitivity t সম্পূর্ণ নথি পড়ুন